Observational retrospective study To characterize and assess clinical outcomes of patients Receiving tezepelumab in the framework Of use in Special Situations prior to commercialisation in Spain

Trial Identifier: D5180R00028
Sponsor: AstraZeneca
Start Date: June 2024
Primary Completion Date: October 2024
Study Completion Date: October 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Spain Alcazar de San Juan, Spain
Spain Almeria, Spain
Spain Badajoz, Spain
Spain Bilbao, Spain
Spain Coslada, Spain
Spain Fuenlabrada, Spain
Spain Gran Canaria, Spain
Spain Lugo, Spain
Spain Madrid, Spain
Spain Malaga, Spain
Spain San Sebastian, Spain
Spain Talavera de la Reina, Spain
Spain Torrejon de Ardoz, Spain
Spain Valencia, Spain